Diabetes & Vascular Disease Research
Diabetes & Vascular Disease Research is the first international peer-reviewed journal to unite diabetes and vascular disease in a single title. Diabetes & Vascular Disease Research is an open access journal.
It mirrors the increasing recognition that diabetes and cardiovascular disease are a single entity in which diabetes and related disorders, such as insulin resistance, are directly linked with assaults on the vessel wall and the development of vascular risk clustering.
Diabetes & Vascular Disease Research:
- Links diabetes, its metabolic consequences and vascular outcomes
- Original research in fields of insulin resistance and metabolic disorders
- Promotes understanding of pathology, aetiology and management of thrombosis, hyperglycaemia, hypertension, dyslipidaemia and micro- and macrovascular consequences.
This journal is a member of the Committee on Publication Ethics (COPE).
Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons license. The APC for this journal is currently 2100 USD.
The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.
This journal changed its publication mode from subscription to open access in January 2020.
Submit your manuscript today at https://mc.manuscriptcentral.com/dvdres.
Diabetes & Vascular Disease Research is the first international peer-reviewed journal to unite diabetes and vascular disease in a single title. Diabetes & Vascular Disease Research is an open access journal.
It mirrors the increasing recognition that diabetes and cardiovascular disease are a single entity in which diabetes and related disorders, such as insulin resistance, are directly linked with assaults on the vessel wall and the development of vascular risk clustering.
Diabetes & Vascular Disease Research:
- Links diabetes, its metabolic consequences and vascular outcomes
- Original research in fields of insulin resistance and metabolic disorders
- Promotes understanding of pathology, aetiology and management of thrombosis, hyperglycaemia, hypertension, dyslipidaemia and micro- and macrovascular consequences.
| Peter Grant | Leeds University UK |
| Ramzi Ajjan | Leeds University, UK |
| Clifford J Bailey | Aston University, UK |
| Nikolaus Marx | University of Aachen, Germany |
| Katharina Schütt | University Hospital Aachen, RWTH University, Germany |
| David A. Russell | Leeds Teaching Hospitals NHS Trust and University of Leeds, UK |
| Darren McGuire | University of Texas Southwestern Medical Centre, USA |
| Mark Cooper | Monash University, Austalia |
| Dinesh Selvarajah | University of Sheffield, UK |
| Matthew Campbell | University of Sunderland, UK |
| Evelyn Mensah | London North West University NHS Trust, UK |
| Jean Pierre Riveline | Université Paris-Cité, France |
| Nithya Sukumar | Warwick University, UK |
| Carlos Alvarez | University of Texas, Southwestern Medical Center, USA |
| Lina Badimon | Hospital de la Santa Creu I Sant Pau, Spain |
| Stefano Del Prato | University of Pisa, Italy |
| Odette Gore | University of Texas Southwestern Medical Center, USA |
| Mansoor Husain | University of Toronto, Canada |
| Silvio Inzucchi | Yale University School of Medicine, USA |
| Florian Kahles | Harvard Medical School, USA |
| Mark Kearney | Leeds University, UK |
| Ildiko Lingvay | University of Texas, Southwestern Medical Center, USA |
| John Petrie | University of Glasgow, UK |
| Carolyn Lam Su Ping | National University Heart Centre, Singapore |
| Jorge Plutzky | Harvard Medical School, USA |
| Paul M Ridker | Brigham & Women's Hospital, USA |
| Bianca Rocca | Catholic University School of Medicine, Italy |
| Lars Ryden | Karolinska University Hospital, Sweden |
| Gaetano Santulli | Albert Einstein College of Medicine, USA |
| Bart Staels | Universiti Lille Nord de France, France |
| E Standl | Diabetes Research Institute, Germany |
| Paul Zimmet | International Diabetes Insitute, Australia |
Manuscript submission guidelines can be accessed on Sage Journals.